AUTHOREA
Log in Sign Up Browse Preprints

January 20, 2022
Anti-CD19 CAR T as a feasible and safe therapy for refractory/relapsed mixed phenotyp...
Xiangqun Li, Kylann Chen, Hailong Zhang, et al.